{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:49:57Z","timestamp":1787068197284,"version":"build-2736575974"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi250074-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Vasa previa, although a rare condition affecting 0.46 per 1000 pregnancies, results in high rates of fetal and neonatal mortality and morbidity. Widespread use of a core outcome set and reporting checklist may enable data harmonization, enhance evidence synthesis, and ensure prioritization of patient-important outcomes in clinical practice, future research, and clinical practice guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250074-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop a core outcome set for studies on vasa previa that includes perinatal screening, diagnosis, and management of vasa previa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250074-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This survey study involved a 2-round international and cross-disciplinary Delphi survey and virtual consensus meetings conducted between March 14, 2021, and October 4, 2022. Health care professionals (HCPs) and health service users (HSUs) were invited to participate in the development of the core outcome set.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250074-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Perinatal screening, diagnosis, and management of vasa previa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250074-8\">\n                    <jats:title>Main Outcome and Measures<\/jats:title>\n                    <jats:p>Core outcomes and reporting checklist items for future studies on vasa previa were developed using Delphi surveys, small group discussions, and a consensus meeting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250074-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>An international group of 204 participants, comprising 115 HSUs and 89 HCPs representing 27 countries, rated 67 outcomes identified through a systematic review and qualitative interviews in a 2-round online Delphi survey. Through virtual small group discussions and a consensus meeting, 13 core outcomes were identified: pregnancy outcome (live birth, fetal loss [miscarriage or stillbirth], or neonatal death), severe neonatal morbidity, fetal\/neonatal blood loss, neonatal intensive care unit admission for &amp;amp;gt;24 hours, gestational age at birth, third trimester confirmation of vasa previa diagnosis, neurocognitive and developmental outcomes, mode of birth, maternal death or severe morbidity, maternal quality of life, duration of antepartum admission, and antepartum or peripartum hemorrhage. A 22-item reporting checklist was simultaneously developed to include important items in studies on vasa previa when possible and\/or relevant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi250074-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The core outcome set and reporting checklist for vasa previa are hoped to encourage researchers to incorporate patient-important outcomes in future studies to enable data harmonization, improve evidence synthesis, and facilitate the development of clinical practice guidelines for this rare and highly lethal condition for which timely diagnosis and management may prevent fetal and maternal morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.1000","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:02:37Z","timestamp":1742295757000},"page":"e251000","source":"Crossref","is-referenced-by-count":6,"title":["Core Outcome Set and Reporting Checklist for Studies on Vasa Previa"],"prefix":"10.1001","volume":"8","author":[{"given":"Tiffany","family":"Yeretsian","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada"},{"name":"Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Javid","sequence":"additional","affiliation":[{"name":"Sydney Institute for Women, Children and Their Families, Sydney Local Health District, Sydney, New South Wales, Australia"},{"name":"South Western Sydney Local Health District, Liverpool, New South Wales, Australia"},{"name":"Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Hirschhorn-Edwards","sequence":"additional","affiliation":[{"name":"School of Population Health, University of New South Wales, Sydney, Australia"},{"name":"International Vasa Previa Foundation, Chester, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwana","family":"Ashraf","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kingdom","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"D\u2019Souza","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"3","key":"zoi250074r1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/AOG.0000000000005287","article-title":"Vasa previa.","volume":"142","author":"Oyelese","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi250074r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100117","article-title":"Vasa previa and associated risk factors: a systematic review and meta-analysis.","volume":"2","author":"Pavalagantharajah","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"5 Pt 1","key":"zoi250074r3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/01.AOG.0000123245.48645.98","article-title":"Vasa previa: the impact of prenatal diagnosis on outcomes.","volume":"103","author":"Oyelese","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi250074r4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/AOG.0000000000002198","article-title":"Vasa previa diagnosis, clinical practice, and outcomes in Australia.","volume":"130","author":"Sullivan","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi250074r5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ijgo.12747","article-title":"A survey of opinion and practice regarding prenatal diagnosis of vasa previa among obstetricians from Australia and New Zealand.","volume":"144","author":"Javid","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"zoi250074r6","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5608","article-title":"Vasa previa: a rare obstetric complication-a case series and a literature review.","volume":"10","author":"Degirmenci","year":"2022","journal-title":"Clin Case Rep"},{"issue":"2","key":"zoi250074r7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/uog.7466","article-title":"Diagnosis and management of vasa previa: a questionnaire survey.","volume":"35","author":"Ioannou","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"zoi250074r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100116","article-title":"Variations in reported outcomes in studies on vasa previa: a systematic review.","volume":"2","author":"Villani","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"2","key":"zoi250074r9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.wombi.2018.06.020","article-title":"The experience of vasa praevia for Australian midwives: a qualitative study.","volume":"32","author":"Javid","year":"2019","journal-title":"Women Birth"},{"key":"zoi250074r10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/1471-2393-14-318","article-title":"\u201cWrapping myself in cotton wool\u201d: Australian women\u2019s experience of being diagnosed with vasa praevia.","volume":"14","author":"Javid","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"zoi250074r11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.midw.2018.10.011","article-title":"Providing quality care for women with vasa praevia: challenges and barriers faced by Australian midwives.","volume":"68","author":"Javid","year":"2019","journal-title":"Midwifery"},{"key":"zoi250074r12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET handbook: version 1.0.","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"issue":"1","key":"zoi250074r13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5688\/aj720111","article-title":"Best practices for survey research reports: a synopsis for authors and reviewers.","volume":"72","author":"Draugalis","year":"2008","journal-title":"Am J Pharm Educ"},{"issue":"11","key":"zoi250074r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002447","article-title":"Core Outcome Set-Standards for Development: the COS-STAD recommendations.","volume":"14","author":"Kirkham","year":"2017","journal-title":"PLoS Med"},{"issue":"7","key":"zoi250074r16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034018","article-title":"Core Outcome Set for Studies on Pregnant Women With Vasa Previa (COVasP): a study protocol.","volume":"10","author":"D\u2019Souza","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"zoi250074r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.wombi.2024.101614","article-title":"Women- and clinician-important outcomes and priorities regarding vasa praevia: an international qualitative study to inform development of a core outcome set.","volume":"37","author":"Javid","year":"2024","journal-title":"Women Birth"},{"key":"zoi250074r19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jclinepi.2017.12.020","article-title":"A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery.","volume":"96","author":"Dodd","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"zoi250074r20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider.","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"issue":"5","key":"zoi250074r21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/jtr.709","article-title":"Moving best practice forward: Delphi characteristics, advantages, potential problems, and solutions.","volume":"11","author":"Donohoe","year":"2009","journal-title":"Int J Tour Res"},{"issue":"7","key":"zoi250074r22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201378","article-title":"Recruiting and retaining participants in e-Delphi surveys for core outcome set development: evaluating the COMiT\u2019ID study.","volume":"13","author":"Hall","year":"2018","journal-title":"PLoS One"},{"key":"zoi250074r23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jclinepi.2018.12.010","article-title":"Higher number of items associated with significantly lower response rates in COS Delphi surveys.","volume":"108","author":"Gargon","year":"2019","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"zoi250074r24","doi-asserted-by":"publisher","first-page":"339.e1","DOI":"10.1016\/j.ajog.2019.05.039","article-title":"A core outcome set for the prevention and treatment of fetal growth restriction: developing endpoints: the COSGROVE study.","volume":"221","author":"Healy","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"13","key":"zoi250074r25","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1111\/1471-0528.16780","article-title":"Important research outcomes for treatment studies of perinatal depression: systematic overview and development of a core outcome set.","volume":"128","author":"Hellberg","year":"2021","journal-title":"BJOG"},{"issue":"10","key":"zoi250074r26","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/1471-0528.14694","article-title":"Core outcome sets in women\u2019s and newborn health: a systematic review.","volume":"124","author":"Duffy","year":"2017","journal-title":"BJOG"},{"key":"zoi250074r27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jclinepi.2019.06.016","article-title":"A systematic review of core outcome set development studies demonstrates difficulties in defining unique outcomes.","volume":"115","author":"Young","year":"2019","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"zoi250074r28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/AOG.0000000000001195","article-title":"A core outcome set for evaluation of interventions to prevent preterm birth.","volume":"127","author":"van \u2019t Hooft","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"1","key":"zoi250074r29","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.23889\/ijpds.v5i1.1337","article-title":"A composite neonatal adverse outcome indicator using population-based data: an update.","volume":"5","author":"Todd","year":"2020","journal-title":"Int J Popul Data Sci"},{"issue":"4","key":"zoi250074r30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/archdischild-2019-317501","article-title":"Core outcomes in neonatology: development of a core outcome set for neonatal research.","volume":"105","author":"Webbe","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"zoi250074r32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/ppe.12574","article-title":"Severe maternal morbidity surveillance: monitoring pregnant women at high risk for prolonged hospitalisation and death.","volume":"34","author":"Dzakpasu","year":"2020","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"1","key":"zoi250074r33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s13063-016-1555-2","article-title":"How to select outcome measurement instruments for outcomes included in a \u201ccore outcome set\u201d - a practical guideline.","volume":"17","author":"Prinsen","year":"2016","journal-title":"Trials"},{"key":"zoi250074r34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ahj.2024.09.008","article-title":"Outcome reporting in cardio-obstetrics studies: a systematic review.","volume":"278","author":"Hall","year":"2024","journal-title":"Am Heart J"},{"key":"zoi250074r14","unstructured":"Outcome Reporting in Obstetric Studies (OROS) Project. McMaster University. Accessed February 10, 2025. https:\/\/oros-project.com\/"},{"key":"zoi250074r17","unstructured":"Javid? N, Kingdom? J, Krznaric? M, Donnelley? N, D\u2019Souza? R. Developing a core outcome set for studies on pregnant women with vasa previa. COMET Initiative; 2024. Accessed February 10, 2025. https:\/\/www.comet-initiative.org\/Studies\/Details\/1117"},{"key":"zoi250074r31","unstructured":"Identifying severe maternal morbidity (SMM). Centers for Disease Control and Prevention. Accessed February 10, 2025. https:\/\/www.cdc.gov\/maternal-infant-health\/php\/severe-maternal-morbidity\/icd.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/smm\/severe-morbidity-ICD.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2831669\/yeretsian_2025_oi_250074_1741708858.50868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:02:42Z","timestamp":1742295762000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2831669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.1000","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]}}}